Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, United States.
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, United States; Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA, United States.
Methods Enzymol. 2024;707:63-99. doi: 10.1016/bs.mie.2024.07.054. Epub 2024 Aug 22.
Mitochondrial function is dependent on the correct localization and insertion of membrane proteins into the outer mitochondrial membrane (OM). In mammals, the OM contains ∼150 proteins, the majority of which contain α-helical transmembrane domains. This family of α-helical proteins has significantly expanded in metazoans and has evolved to mediate critical signaling and regulatory processes including mitochondrial fusion and fission, mitophagy, apoptosis and aspects of the innate immune response. Recently, the conserved OM protein MTCH2 has been identified as an insertase for α-helical proteins in human mitochondria. However, our understanding of the targeting, insertion, folding and quality control of α-helical OM proteins remains incomplete. Here we highlight three methods to monitor α-helical protein insertion both in human cells and in vitro. First, we describe a versatile split fluorescent reporter system that can be used to monitor the insertion of α-helical proteins into the OM in human cells. Second, we delineate a streamlined approach to isolating functional, insertion competent mitochondria from human cells that are compatible with in vitro import assays. Finally, we explain in detail how to reconstitute the insertion of α-helical proteins in a minimal system, by creating functional proteoliposomes containing purified MTCH2. Together these tools represent an integrated platform to enable the detailed mechanistic analysis of biogenesis of the diverse and physiologically essential α-helical OM proteome.
线粒体的功能依赖于膜蛋白在其外膜(OM)上的正确定位和插入。在哺乳动物中,OM 包含约 150 种蛋白质,其中大多数含有α-螺旋跨膜结构域。这个α-螺旋蛋白家族在后生动物中显著扩张,并进化为介导关键的信号和调节过程,包括线粒体融合和分裂、线粒体自噬、细胞凋亡和先天免疫反应的某些方面。最近,保守的 OM 蛋白 MTCH2 被鉴定为人线粒体中α-螺旋蛋白的插入酶。然而,我们对α-螺旋 OM 蛋白的靶向、插入、折叠和质量控制的理解仍然不完整。在这里,我们强调了三种方法来监测α-螺旋蛋白在人类细胞和体外的插入。首先,我们描述了一种通用的分裂荧光报告系统,可用于监测α-螺旋蛋白在人类细胞中插入 OM 的情况。其次,我们描述了一种从人类细胞中分离功能正常、插入能力强的线粒体的简化方法,该方法与体外导入实验兼容。最后,我们详细解释了如何通过创建含有纯化 MTCH2 的功能性脂蛋白体,在最小系统中重新构建α-螺旋蛋白的插入。这些工具共同构成了一个综合平台,能够对多样化且生理上必需的α-螺旋 OM 蛋白质组的生物发生进行详细的机制分析。